SHANGHAI LABWAY CLINICAL LABORATORY CO., LTD

Andere Sprachen Shanghai Labway Clinical Laboratory Co., Ltd

Aktien

301060

CNE100004RG8

301060

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 01.07.2024			% 5 Tage	% 1. Jan.
8.21 ^CNY	+1.11%		-4.53%	-38.22%

26.04.	Shanghai Labway Clinical Laboratory Co., Ltd berichtet über die Ergebnisse für das erste Quartal bis zum 31. März 2024	CI
2023	Shanghai Labway Clinical Laboratory Co., Ltd (SZSE:301060) kündigt einen Aktienrückkauf im Wert von CNY 30 Millionen an.	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Labway Clinical Laboratory Names Chief Financial Officer	30.05.
Shanghai Labway Clinical Laboratory Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	26.04.
Tranche Update on Shanghai Labway Clinical Laboratory Co., Ltd's Equity Buyback Plan announced on November 16, 2023.	02.04.
Tranche Update on Shanghai Labway Clinical Laboratory Co., Ltd's Equity Buyback Plan announced on November 16, 2023.	04.01.
Shanghai Labway Clinical Laboratory Co., Ltd announces an Equity Buyback for CNY 30 million worth of its shares.	16.11.
Shanghai Labway Clinical Laboratory Co., Ltd authorizes a Buyback Plan.	11.11.
Shanghai Labway Clinical Laboratory Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27.10.23
Certain A Shares of Shanghai Labway Clinical Laboratory Co., Ltd. are subject to a Lock-Up Agreement Ending on 14-SEP-2023.	14.09.23
Shanghai Labway Clinical Laboratory Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	30.08.23
Labway Clinical Laboratory to Buy Enterprise Management Firm For 283 Million Yuan	10.07.23
Shanghai Labway Clinical Laboratory Co., Ltd Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 20, 2023	14.06.23
Shanghai Labway Clinical Laboratory Co., Ltd Approves Cash Dividend for 2022	29.05.23
Shanghai Labway Clinical Laboratory Co., Ltd Proposes Final Cash Dividend for the Year 2022	27.04.23
Shanghai Labway Clinical Laboratory Co., Ltd cancelled the transaction announced on September 1, 2022	27.04.23
Shanghai Labway Clinical Laboratory Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	26.04.23
Shanghai Labway Clinical Laboratory Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	19.04.23
As China seeks to live with the virus, COVID-control industries face decline	16.12.22
Chinese COVID testing firms report big profits as virus fight intensifies	03.11.22
Shanghai Labway Clinical Laboratory Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27.10.22
Shanghai Labway Clinical Laboratory Co., Ltd.(XSEC:301060) added to S&P Global BMI Index	19.09.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Shanghai Labway Clinical Laboratory Co., Ltd

Aktien

301060

CNE100004RG8

301060

Andere Sprachen

Filter